Exelixis Clinical Site #51

Brussels 1200

0 studies enrolling now · 2 studies all time

What they study most

Colorectal Cancer, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer, Neoplasm Malignant, Renal Cell Carcinoma

Studies at this site

• Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer — Running, not enrolling
• A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors — Running, not enrolling